Topologically inferring risk-active pathways toward precise cancer classification by directed random walk. - Wei Liu 187; Chunquan Li 002; Yanjun Xu; Haixiu Yang; Qianlan Yao; Junwei Han 003; Desi Shang; Chunlong Zhang; Fei Su; Xiaoxi Li; Yun Xiao 001; Fan Zhang; et al. (Bioinform., 2013)

The detection of risk pathways, regulated by miRNAs, via the integration of sample-matched miRNA-mRNA profiles and pathway structure. - Jing Li 115; Chunquan Li 002; Junwei Han 003; Chunlong Zhang; Desi Shang; Qianlan Yao; Yunpeng Zhang; Yanjun Xu; Wei Liu 187; Meng Zhou 003; Haixiu Yang; Fei Su; et al. (J. Biomed. Informatics, 2014)

psSubpathway: a software package for flexible identification of phenotype-specific subpathways in cancer progression. - Junwei Han 003; Xudong Han; Qingfei Kong; Liang Cheng 006 (Bioinform., 2020)

CNA2Subpathway: identification of dysregulated subpathway driven by copy number alterations in cancer. - Yuqi Sheng; Ying Jiang; Yang Yang 009; Xiangmei Li; Jiayue Qiu; Jiashuo Wu; Liang Cheng 006; Junwei Han 003 (Briefings Bioinform., 2021)

SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs. - Xudong Han; Qingfei Kong; Chonghui Liu; Liang Cheng 006; Junwei Han 003 (Bioinform., 2021)

LncSEA: a platform for long non-coding RNA related sets and enrichment analysis. - Jiaxin Chen; Jian Zhang 084; Yu Gao; Yanyu Li; Chenchen Feng; Chao Song; Ziyu Ning; Xinyuan Zhou; Jianmei Zhao; Minghong Feng; Yuexin Zhang; Ling Wei; et al. (Nucleic Acids Res., 2021)

A novel pathway mutation perturbation score predicts the clinical outcomes of immunotherapy. - Xiangmei Li; Yalan He; Jiashuo Wu; Jiayue Qiu; Ji Li; Qian Wang; Ying Jiang; Junwei Han 003 (Briefings Bioinform., 2022)

DRviaSPCN: a software package for drug repurposing in cancer via a subpathway crosstalk network. - Jiashuo Wu; Xiangmei Li; Qian Wang; Junwei Han 003 (Bioinform., 2022)

iATMEcell: identification of abnormal tumor microenvironment cells to predict the clinical outcomes in cancer based on cell-cell crosstalk network. - Yuqi Sheng; Jiashuo Wu; Xiangmei Li; Jiayue Qiu; Ji Li; Qinyu Ge; Liang Cheng 006; Junwei Han 003 (Briefings Bioinform., 2023)

DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19. - Yinchun Su; Jiashuo Wu; Xiangmei Li; Ji Li; Xilong Zhao; Bingyue Pan; Junling Huang; Qingfei Kong; Junwei Han 003 (Comput. Biol. Medicine, 2023)

IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA-miRNA interaction network constructed through gene expression data. - Jiashuo Wu; Xilong Zhao; Yalan He; Bingyue Pan; Jiyin Lai; Miao Ji; Siyuan Li; Junling Huang; Junwei Han 003 (Briefings Bioinform., 2024)

Knowledge-Based Artificial Intelligence System for Drug Prioritization. - Yinchun Su; Jiashuo Wu; Xilong Zhao; Yue Hao 008; Ziyi Wang; Yongbao Zhang; Yujie Tang; Bingyue Pan; Guangyou Wang; Qingfei Kong; Junwei Han 003 (J. Chem. Inf. Model., 2025)